These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 391285)

  • 1. Physiological and pharmacological effects of estrogens in breast cancer.
    Leclercq G; Heuson JC
    Biochim Biophys Acta; 1979 Dec; 560(4):427-55. PubMed ID: 391285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and progesterone receptor proteins in breast cancer.
    Edwards DP; Chamness GC; McGuire WL
    Biochim Biophys Acta; 1979 Dec; 560(4):457-86. PubMed ID: 391286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of steroid hormone action in breast cancer and its clinical implications.
    Lunenfeld B; Geier A
    Isr J Med Sci; 1981; 17(9-10):954-9. PubMed ID: 7031015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ; Jelovac D; Thiantanawat A; Brodie AM
    Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects and mechanism of action of antiestrogens in breast cancer].
    Borgna JL; Rochefort H
    Sem Hop; 1984 Mar; 60(10):703-9. PubMed ID: 6322320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for breast cancer therapy with antiestrogens.
    Jordan VC; Fritz NF; Gottardis MM
    J Steroid Biochem; 1987; 27(1-3):493-8. PubMed ID: 3320539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of new drugs for endocrine tumour chemotherapy.
    von Angerer E
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():147-53. PubMed ID: 6547370
    [No Abstract]   [Full Text] [Related]  

  • 11. Thermal gradient and response to estrogens or antiestrogens in advanced breast cancer.
    Di Pietro S; Rovini D; Luini A; Muscolino G; Viganotti G
    Tumori; 1980 Aug; 66(4):459-65. PubMed ID: 7414710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of estrogen and antiestrogen action in mammary cancer.
    Katzenellenbogen BS; Rorke EA; Eckert RL
    J Steroid Biochem; 1981 Dec; 15():219-29. PubMed ID: 7339248
    [No Abstract]   [Full Text] [Related]  

  • 13. New role of endocrine therapy in breast cancer.
    Kennedy BJ
    Int J Radiat Oncol Biol Phys; 1978; 4(5-6):469-72. PubMed ID: 689948
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism of estrogens in breast cancer.
    Dao TL
    Biochim Biophys Acta; 1979 Dec; 560(4):397-426. PubMed ID: 391284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The modulators of the estrogenic activity].
    Kirkiacharian S
    Ann Pharm Fr; 2000 Dec; 58(6):383-91. PubMed ID: 11148373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormones and breast cancer in vitro.
    Dickson RB; Thompson EW; Lippman ME
    Hum Cell; 1989 Sep; 2(3):219-30. PubMed ID: 2519209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.
    Jordan VC; Brodie AM
    Steroids; 2007 Jan; 72(1):7-25. PubMed ID: 17169390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.
    Hoffmann J; Bohlmann R; Heinrich N; Hofmeister H; Kroll J; Künzer H; Lichtner RB; Nishino Y; Parczyk K; Sauer G; Gieschen H; Ulbrich HF; Schneider MR
    J Natl Cancer Inst; 2004 Feb; 96(3):210-8. PubMed ID: 14759988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent progress of endocrine therapy in breast cancer].
    Nomura Y
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):783-9. PubMed ID: 1605654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells.
    Ramamoorthy K; Gupta MS; Sun G; McDougal A; Safe SH
    Carcinogenesis; 1999 Jan; 20(1):115-23. PubMed ID: 9934858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.